Cited by 344Growth Hormone and Insulin-like Growth FactorsFibroblast Growth Factor ResearchPancreatic function and diabetes

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1

LeRoith, Derek, Yakar, Shoshana·2007·Nature Clinical Practice Endocrinology & Metabolism

DOI 10.1038/ncpendmet0427

Open this paper in CoChat — free account

Abstract

Insulin-like growth factor (IGF) 1 is a member of a family that is involved in growth, development, cell differentiation, and metabolism. IGF1, IGF2 and insulin act primarily through tyrosine-kinase-linked receptors--the IGF1 receptor (IGF1R) and insulin receptor (IR). The IGF1R binds IGF1 and IGF2 with high affinity and the IR binds insulin with high affinity; however, since both receptors share a high degree of structural and functional homology, the IGF1R can bind insulin and the IR can bind the IGFs with reduced affinity. These two receptors can, moreover, form heterodimers, which bind both ligands. Upon binding to the receptors, cascades of tyrosine and serine kinases are stimulated to facilitate growth or metabolism. The IGF2 receptor is a scavenger receptor, and is, therefore, not involved in mediation of growth or metabolic effects of the IGF family and will not be discussed in the current article. IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and development; however, IGF1 has actions distinct from those of growth hormone in carbohydrate, lipid, and protein metabolism. For example, excess growth hormone causes insulin resistance and hyperglycemia, whereas IGF1 has insulin-like effects that reduce blood glucose levels and has been used experimentally to treat both type 1 and type 2 diabetes.

Integrity signals

Registry

Crossref · 10.1038/ncpendmet0427

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,739
Effects of Human Growth Hormone in Men over 60 Years Old
Rudman, D. R., Feller, A. G., Nagraj, H. S., Gergans, G. A., Lalitha, P. Y., Goldberg, A. F., Schlenker, R. A., Cohn, L., Rudman, I. W., & Mattson, D. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230101 · Cited by 1,545
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J., STANNARD, B. S., Butler, A. A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,418
Self-citation
Increased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
INCREASED MORTALITY ASSOCIATED WITH GROWTH HORMONE TREATMENT IN CRITICALLY ILL ADULTS
Akala, J. U. T., Uokonen, E. S. R., Igel, N., Ebster, R. W., Ielsen, M. I. S. N., Andstra, D. U. F. Z., Undelinckx, G. U. V., & Inds, H. J. H. (1999) · Cited by 889
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. Å., Edén, S., Lönn, L., Kvist, H., Stokland, A. M., Lindstedt, G., Bosaeus, I. G., Tölli, J., Sjöström, L., & Isaksson, O. G. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 780
Roles of Growth Hormone and Insulin-like Growth Factor 1 in Mouse Postnatal Growth
Lupu, F. I., Terwilliger, J. D., Lee, K., Segre, G. V., & Efstratiadis, A. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9975 · Cited by 769
Fat cell adrenergic receptors and the control of white and brown fat cell function
Lafontan, M., & Berlan, M. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37695-1 · Cited by 644
Assessment of Growth Parameters and Life Span of GHR/BP Gene-Disrupted Mice 1
Coschigano, K. T., Clemmons, D., Bellush, L. L., & Kopchick, J. J. (2000) · Endocrinology · doi:10.1210/endo.141.7.7586 · Cited by 611
Targeted Disruption of the β3-Adrenergic Receptor Gene
Susulic, V. S., Frederich, R. C., Lawitts, J. A., Tozzo, E., Kahn, B. B., Harper, M., Himms‐Hagen, J., Flier, J. S., & Lowell, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29483 · Cited by 493

Show all 71 references

Sorted by citations

Diabetes and cancer
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Acromegaly pathogenesis and treatment
Melmed, S. K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 704
Identification of Adropin as a Secreted Factor Linking Dietary Macronutrient Intake with Energy Homeostasis and Lipid Metabolism
Kumar, K. G., Trevaskis, J. L., Lam, D. D., Sutton, G. M., Koza, R. A., Chouljenko, V. N., Kousoulas, K. G., Rogers, P. M., Kesterson, R. A., Thearle, M. S., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.011 · Cited by 516
Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.006 · Cited by 409
Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays
Clemmons, D. R. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.150631 · Cited by 352
Insulin-like growth factor-1 deficiency and metabolic syndrome
Aguirre, G. A., Ita, J. R. D., de la Garza, R. G., & Castilla‐Cortázar, I. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0762-z · Cited by 297
Brain IGF-1 Receptors Control Mammalian Growth and Lifespan through a Neuroendocrine Mechanism
Kappeler, L., Filho, C. D. D. M., Dupont, J., Leneuve, P., Cervera, P., Périn, L., Loudes, C., Blaise, A., Klein, R., Epelbaum, J., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060254 · Cited by 305
Reversal of Type 1 Diabetes in Mice by Brown Adipose Tissue Transplant
Gunawardana, S. C., & Piston, D. W. (2012) · Diabetes · doi:10.2337/db11-0510 · Cited by 290
Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance
Kumar, K. G., Zhang, J., Gao, S., Rossi, J., McGuinness, O. P., Halem, H. H., Culler, M. D., Mynatt, R. L., & Butler, A. A. (2012) · Obesity · doi:10.1038/oby.2012.31 · Cited by 262
Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism
Fan, Y., Menon, R. K., Cohen, P., Hwang, D., Clemens, T. L., DiGirolamo, D. J., Kopchick, J. J., Roith, D. L., Trucco, M., & Sperling, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014308 · Cited by 260
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Kasprzak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126434 · Cited by 248
FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization
O-Sullivan, I., Zhang, W., Wasserman, D. H., Liew, C. W., Liu, J., Paik, J., DePinho, R. A., Stolz, D. B., Kahn, C. R., Schwartz, M. W., et al. (2015) · Nature Communications · doi:10.1038/ncomms8079 · Cited by 228
Phenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
IGF-1R as an anti-cancer target--trials and tribulations
Chen, H. X., & Sharon, E. (2013) · 癌症：英文版 · doi:10.5732/cjc.012.10263 · Cited by 202
The IGF system
Annunziata, M., Granata, R., & Ghigo, E. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0227-z · Cited by 201
The current status of IGF-I assays – A 2009 update
Frystyk, J., Freda, P. U., & Clemmons, D. R. (2009) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.09.004 · Cited by 196
Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development
Hellström, A., Ley, D., Pupp, I. H., Hallberg, B., Löfqvist, C., Marter, L. J. V., van Weissenbruch, M. M., Ramenghi, L. A., Beardsall, K., Dunger, D. B., et al. (2016) · Acta Paediatrica · doi:10.1111/apa.13350 · Cited by 190
Effects of growth hormone on glucose metabolism and insulin resistance in human
Kim, S.-H., & Park, M.-J. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.3.145 · Cited by 181
Eight-Hour Time-Restricted Feeding Improves Endocrine and Metabolic Profiles in Women with Anovulatory Polycystic Ovary Syndrome
Li, C., Xing, C., Zhang, J., Zhao, H., Shi, W., & He, B. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02817-2 · Cited by 180
Signaling in Cell Differentiation and MorphogenesisPreprint
Basson, M. A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008151 · Cited by 181
Exercise and the Growth Hormone-Insulin-Like Growth Factor Axis
Frystyk, J. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b07d2d · Cited by 171
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J. (2015) · Nature Communications · doi:10.1038/ncomms8078 · Cited by 169
Insulin and Insulin-like Growth Factor-1 Receptors Act as Ligand-specific Amplitude Modulators of a Common Pathway Regulating Gene Transcription
Boucher, J., Tseng, Y., & Kahn, C. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118620 · Cited by 163
Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions
Kleinberg, D. L., Wood, T. L., Furth, P. A., & Lee, A. V. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0022 · Cited by 162
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
Sommerfeld, M. R., Müller, G. A., Tschank, G., Seipke, G., Habermann, P., Kurrle, R., & Tennagels, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009540 · Cited by 150
p53 and metabolism: from mechanism to therapeutics
Simabuco, F. M., Morale, M. G., Pavan, I. C. B., Morelli, A. P., Silva, F. R., & Tamura, R. E. (2018) · Oncotarget · doi:10.18632/oncotarget.25267 · Cited by 159
Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women
Rajpathak, S. N., He, M., Sun, Q., Kaplan, R. C., Muzumdar, R. H., Rohan, T. E., Gunter, M. J., Pollak, M., Kim, M., Pessin, J. E., et al. (2012) · Diabetes · doi:10.2337/db11-1488 · Cited by 148
Trichothecene toxicity in eukaryotes: Cellular and molecular mechanisms in plants and animals
Arunachalam, C., & Doohan, F. M. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.12.003 · Cited by 153
Regulation of GH and GH Signaling by Nutrients
Caputo, M., Pigni, S., Agosti, E., Daffara, T., Ferrero, A., Filigheddu, N., & Prodam, F. (2021) · Cells · doi:10.3390/cells10061376 · Cited by 159
Growth Hormone Induces Hepatic Production of Fibroblast Growth Factor 21 through a Mechanism Dependent on Lipolysis in Adipocytes
Chen, W., Hoo, R. L. C., Konishi, M., Itoh, N., Lee, P.-C., Ye, H., Lam, K. S. L., & Xu, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285965 · Cited by 141
Exposure to N-(1,3-dimethylbutyl)-N′-phenyl-p-phenylenediamine (6PPD) affects the growth and development of zebrafish embryos/larvae
Peng, W., Liu, C., Chen, D., Duan, X., & Zhong, L. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113221 · Cited by 138
Role of Insulinlike Growth Factor 1 in Fetal Development and in the Early Postnatal Life of Premature Infants
Hellström, A., Ley, D., Pupp, I. H., Hallberg, B., Ramenghi, L. A., Löfqvist, C., Smith, L. E. H., & Hård, A. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1586109 · Cited by 126
Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
Werner, H. (2011) · Oncogene · doi:10.1038/onc.2011.447 · Cited by 128
The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus
Ahmed, S. A. H., Ansari, S. A., Mensah‐Brown, E. P. K., & Emerald, B. S. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00896-4 · Cited by 131
Diabetes, insulin, and development of acute lung injury
Honiden, S., & Gong, M. N. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a0fea5 · Cited by 125
Insulin-Like Growth Factor 1 Physiology
Yakar, S., & Adamo, M. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.008 · Cited by 125
Self-citation
Interaction of the endocrine system with inflammation: a function of energy and volume regulation
Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4484 · Cited by 121
“Concerning effects of IGF-1 and growth hormone on metabolism, IGF-1 often demonstrates opposite effects to growth hormone [57].”
BackgroundInfluential
Insulin‐like growth factor‐1 stimulates regulatory T cells and suppresses autoimmune disease
Bilbao, D., Luciani, L., Jóhannesson, B., Piszczek, A., & Rosenthal, N. A. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303376 · Cited by 121
Minireview: Mechanisms of Growth Hormone-Mediated Gene Regulation
Chia, D. J. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1099 · Cited by 118
Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver
Hinrichs, A., Kessler, B., Kurome, M., Blutke, A., Kemter, E., Bernau, M., Scholz, A. M., Rathkolb, B., Renner, S., Bultmann, S., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.006 · Cited by 96
Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications
Stefan, N., Häring, H., Hu, F. B., & Schulze, M. B. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00474-x · Cited by 107
One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology
Argente, J., Chowen, J. A., Jurado, L. A. P., Frystyk, J., & Oxvig, C. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707950 · Cited by 107
Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion
Chu, Y.-W., Schmitz, S., Choudhury, B., Telford, W., Kapoor, V., Garfield, S., Howe, D., & Gress, R. E. (2008) · Blood · doi:10.1182/blood-2008-04-149435 · Cited by 107
Insulin-independent reversal of type 1 diabetes in nonobese diabetic mice with brown adipose tissue transplant
Gunawardana, S. C., & Piston, D. W. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00570.2014 · Cited by 107
Severe insulin resistance syndromes
Angelidi, A. M., Filippaios, A., & Mantzoros, C. S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142245 · Cited by 114
Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21
Guridi, M., Tintignac, L. A. J., Lin, S., Kupr, B., Castets, P., & Rüegg, M. A. (2015) · Science Signaling · doi:10.1126/scisignal.aab3715 · Cited by 98
Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes
Regan, S. L. P., Knight, P. G., Yovich, J. L., Arfuso, F., & Dharmarajan, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.018 · Cited by 98
Insulin-like growth factor-binding protein-6 and cancer
Bach, L. A., Fu, P., & Yang, Z. (2012) · Clinical Science · doi:10.1042/cs20120343 · Cited by 97
Molecular Signatures of the Insulin-Like Growth Factor 1-Mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers
Cevenini, A., Orrù, S., Mancini, A., Alfieri, A., Buono, P., & Imperlini, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082411 · Cited by 98
Longevity effect of IGF ‐1 R +/− mutation depends on genetic background‐specific receptor activation
Xu, J., Gontier, G., Chaker, Z., Lacube, P., Dupont, J., & Holzenberger, M. (2013) · Aging Cell · doi:10.1111/acel.12145 · Cited by 96
Growth hormone and prolactin regulate human neural stem cell regenerative activity
Pathipati, P., Gorba, T., Scheepens, A., Goffin, V., Sun, Y., & Fraser, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.029 · Cited by 93
Suppression of Insulin-Like Growth Factor Acid-Labile Subunit Expression—A Novel Mechanism for Deoxynivalenol-Induced Growth Retardation
Amuzie, C. J., & Pestka, J. J. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp225 · Cited by 92
Perinatal exposure to low-dose 2,2′,4,4′-tetrabromodiphenyl ether affects growth in rat offspring: What is the role of IGF-1?
Suvorov, A., Battista, M., & Takser, L. (2009) · Toxicology · doi:10.1016/j.tox.2009.03.018 · Cited by 87
Insulin and Growth Hormone Balance: Implications for Obesity
Huang, Z., Huang, L., Waters, M. J., & Chen, C. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.04.005 · Cited by 88
The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches
Bruchim, I., Sarfstein, R., & Werner, H. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00076 · Cited by 89
Gene Expression and Release of Growth Factors During Delayed Wound Healing: A Review of Studies in Diabetic Animals and Possible Combined Laser Phototherapy and Growth Factor Treatment to Enhance Healing
Peplow, P. V., & Baxter, G. D. (2012) · Photomedicine and Laser Surgery · doi:10.1089/pho.2012.3312 · Cited by 83
The role of insulin-like growth factor-1 in bone remodeling: A review
Fang, J., Zhang, X., Chen, X., Wang, Z., Zheng, S., Cheng, Y., Liu, S., & Hao, L. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124125 · Cited by 84
Relating Phthalate and BPA Exposure to Metabolism in Peripubescence: The Role of Exposure Timing, Sex, and Puberty
Watkins, D. J., Peterson, K. E., Ferguson, K. K., Mercado‐García, A., Tamayo‐Ortiz, M., Cantoral, A., Meeker, J. D., & Téllez‐Rojo, M. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2706 · Cited by 79
Disorders of growth hormone/insulin-like growth factor secretion and action
Backeljauw, P. F., Dattani, M., Cohen, P., & Rosenfeld, R. G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00019-6 · Cited by 79
Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice
So, W. Y., Cheng, Q., Xu, A., Lam, K. S. L., & Leung, P. S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.80 · Cited by 79
Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency
Matsumoto, R., Fukuoka, H., Iguchi, G., Nishizawa, H., Bando, H., Suda, K., Takahashi, M., & Takahashi, Y. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.07.002 · Cited by 78
A potential role for lamellar insulin-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis
de Laat, M. A., Pollitt, C. C., Kyaw-Tanner, M. T., McGowan, C. M., & Sillence, M. N. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.12.026 · Cited by 75
Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women
Hofmann, M., Halper, B., Oesen, S., Franzke, B., Stuparits, P., Tschan, H., Bachl, N., Strasser, E.-M., Quittan, M., Ploder, M., et al. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.02.008 · Cited by 74
Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease
Rodriguez, S., Gaunt, T. R., & Day, I. (2007) · Human Genetics · doi:10.1007/s00439-007-0378-3 · Cited by 81
Genome-Wide Association Meta-analysis Identifies Novel Variants Associated With Fasting Plasma Glucose in East Asians
Hwang, J., Sim, X., Wu, Y., Liang, J., Tabara, Y., Hu, C., Hara, K., Tam, C. H. T., Cai, Q., Zhao, Q., et al. (2014) · Diabetes · doi:10.2337/db14-0563 · Cited by 70
Brown adipose tissue transplantation as a novel alternative to obesity treatment: a systematic review
Payab, M., Abedi, M., Heravani, N. F., Hadavandkhani, M., Arabi, M., Tayanloo-Beik, A., Hosseini, M. S., Gerami, H., Khatami, F., Larijani, B. A., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0616-5 · Cited by 69
Macrophage and adipocyte IGF 1 maintain adipose tissue homeostasis during metabolic stresses
Chang, H. R., Kim, H. J., Xu, X., & Ferrante, A. W. (2015) · Obesity · doi:10.1002/oby.21354 · Cited by 69
Targeting IGF-1 signaling pathways in gynecologic malignancies
Bruchim, I., & Werner, H. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.749863 · Cited by 66
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Miao, J., Zhang, Y., Chen, S., Zheng, Q., & Guo, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04457-1 · Cited by 73
Effects of medical therapies for acromegaly on glucose metabolism
Urbani, C., Sardella, C., Calevro, A., Rossi, G., Scattina, I., Lombardi, M., Lupi, I., Manetti, L., Martino, E., & Bogazzi, F. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0032 · Cited by 67
Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action
Nagaraj, K., Lapkina-Gendler, L., Sarfstein, R., Gurwitz, D., Pasmanik‐Chor, M., Laron, Z., Yakar, S., & Werner, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715930115 · Cited by 62
Self-citation
Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors
Wittenbecher, C., Kuxhaus, O., Boeing, H., Stefan, N., & Schulze, M. B. (2019) · Diabetologia · doi:10.1007/s00125-019-04978-8 · Cited by 65
Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy
Werner, H., Sarfstein, R., & Bruchim, I. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1694660 · Cited by 62
Molecular and functional characterization of two distinct IGF binding protein-6 genes in zebrafish
Wang, X., Lü, L., Li, Y., Li, M., Chen, C., Feng, Q., Zhang, C., & Duan, C. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90969.2008 · Cited by 61
IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development
Hellström, A., Ley, D., Hallberg, B., Löfqvist, C., Pupp, I. H., Ramenghi, L. A., Borg, J., Smith, L. E. H., & Hård, A. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666171002114545 · Cited by 60
LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice
Touvier, T., Conte-Auriol, F., Briand, O., Cudejko, C., Paumelle, R., Caron, S., Baugé, E., Rouillé, Y., Salles, J., Staels, B., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci34997 · Cited by 59
Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
Werner, H., Sarfstein, R., LeRoith, D., & Bruchim, I. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00159 · Cited by 59
Self-citation
Human Placental Transcriptome Reveals Critical Alterations in Inflammation and Energy Metabolism with Fetal Sex Differences in Spontaneous Preterm Birth
Lien, Y., Zhang, Z., Cheng, Y., Polyák, E., Sillers, L., Falk, M. J., Ischiropoulos, H., Parry, S. I., & Simmons, R. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157899 · Cited by 56
The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency
Sprogøe, K., Mortensen, E., Karpf, D. B., & Leff, J. A. (2017) · Endocrine Connections · doi:10.1530/ec-17-0203 · Cited by 57
Treatment with Recombinant Human Insulin-Like Growth Factor (rhIGF)-I/rhIGF Binding Protein-3 Complex Improves Metabolic Control in Subjects with Severe Insulin Resistance
Regan, F. M., Williams, R. M., McDonald, A. L., Umpleby, A. M., Acerini, C. L., O’Rahilly, S., Hovorka, R., Semple, R. K., & Dunger, D. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2088 · Cited by 56
Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes
Gu, H. F., Gu, T., Hilding, A., Zhu, Y., Kärvestedt, L., Östenson, C., Lai, M., Kutsukake, M., Frystyk, J., Tamura, K., et al. (2013) · Clinical Epigenetics · doi:10.1186/1868-7083-5-20 · Cited by 55
Adult and Near-Adult Height in Patients with Severe Insulin-Like Growth Factor-I Deficiency after Long-Term Therapy with Recombinant Human Insulin-Like Growth Factor-I
Backeljauw, P. F., Kuntze, J., Frane, J. W., Calikoglu, A. S., & Chernausek, S. D. (2013) · Hormone Research in Paediatrics · doi:10.1159/000351958 · Cited by 51
Overall Mortality in Diabetes Mellitus: Where Do We Stand Today?
DAILEY, G. E. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0019 · Cited by 52
Insulin Analogs and Cancer
Sciacca, L., Moli, R. L., & Vigneri, R. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00021 · Cited by 52
Association of circulating insulin‐like growth factor 1 with hepatocellular carcinoma: one cross‐sectional correlation study
Su, W., Lee, K., Yeh, Y., Soon, M., Wang, C., Yu, M., & Wang, S. (2010) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20320 · Cited by 50
Understanding Stunting: Impact, Causes, and Strategy to Accelerate Stunting Reduction—A Narrative Review
Mulyani, A. T., Khairinisa, M. A., Khatib, A., & Chaerunisaa, A. Y. (2025) · Nutrients · doi:10.3390/nu17091493 · Cited by 48
Estrogens Regulate the Hepatic Effects of Growth Hormone, a Hormonal Interplay with Multiple Fates
Fernández‐Pérez, L., Guerra, B., Díaz-Chico, J. C., & Flores‐Morales, A. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00066 · Cited by 49
Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1)
Ketha, H., & Singh, R. J. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.029 · Cited by 47
Metabolic alterations in paediatric GH deficiency
Rothermel, J., & Reinehr, T. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.11.004 · Cited by 48
Teprotumumab-Related Adverse Events in Thyroid Eye Disease
Shah, S., Amarikwa, L., Sears, C. M., Clauss, K. D., Rajjoub, R. D., Kang, J. Y., Tamhankar, M. A., Briceño, C. A., Harrison, A. R., Dosiou, C., et al. (2023) · Ophthalmology · doi:10.1016/j.ophtha.2023.10.018 · Cited by 47
Low Circulating Levels of IGF-1 in Healthy Adults Are Associated With Reduced β-Cell Function, Increased Intramyocellular Lipid, and Enhanced Fat Utilization During Fasting
Thankamony, A., Capalbo, D., Marcovecchio, M., Sleigh, A., Jørgensen, S. W., Hill, N., Mooslehner, K., Yeo, G., Bluck, L., Juul, A., et al. (2014) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2013-4542 · Cited by 45
Insulin-like growth factor-I in wound healing of rat skin
Todorović, V., Peško, P. M., Micev, M. T., Bjelović, M., Budeč, M., Mićić, M., Brasanac, D. C., & Ilić-Stojanović, O. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.05.006 · Cited by 45
Unraveling the complex interplay between transcription factors and signaling molecules in thyroid differentiation and function, from embryos to adults
López-Márquez, A., Carrasco-López, C., Fernández-Méndez, C., & Santisteban, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.654569 · Cited by 49
Eye on the horizon: The metabolic landscape of the RPE in aging and disease
Hansman, D., Du, J., Casson, R. J., & Peet, D. J. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101306 · Cited by 50
Insulin-Like Growth Factor-I and -II Levels Are Associated with the Progression of Nonalcoholic Fatty Liver Disease in Obese Children
Cianfarani, S., Inzaghi, E., Alisi, A., Germani, D., Puglianiello, A., & Nobili, V. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.052 · Cited by 43
IGF-1 and Survival in ESRD
Jia, T., Axelsson, T. G., Heimbürger, O., Barany, P. F., Lindholm, B., Stenvinkel, P., & Qureshi, A. R. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02470213 · Cited by 43
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways
Werner, H., Lapkina-Gendler, L., Achlaug, L., Nagaraj, K., Somri, L., Yaron-Saminsky, D., Pasmanik‐Chor, M., Sarfstein, R., Laron, Z., & Yakar, S. (2019) · Cells · doi:10.3390/cells8060596 · Cited by 41
Self-citation
β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies
Al-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 43
GIGYF2 is present in endosomal compartments in the mammalian brains and enhances IGF‐1‐induced ERK1/2 activation
Higashi, S., Iseki, E., Minegishi, M., Togo, T., Kabuta, T., & Wada, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06930.x · Cited by 43
In Vitro and In Vivo Effects of IGF-1 Delivery Strategies on Tendon Healing: A Review
Miescher, I., Rieber, J., Calcagni, M., & Buschmann, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032370 · Cited by 40

Authors: LeRoith, D., & Yakar, S.
Affiliations: Mount Sinai Hospital (US)
Corresponding author: LeRoith, Derek
ORCID: Yakar, Shoshana
Venue: Nature Clinical Practice Endocrinology & Metabolism
Publisher: Springer Science and Business Media LLC
Published: 2007-03
Volume: 3
Issue: 3
Pages: 302-310
ISSN: 1745-8366 (ISSN-L)
1745-8374
DOI: 10.1038/ncpendmet0427
OpenAlex: W2084967524
Cited by: 344
References: 71
Citations by year: 2026: 11 · 2025: 22 · 2024: 21 · 2023: 18 · 2022: 20 · 2021: 17 · 2020: 25 · 2019: 20 · 2018: 21 · 2017: 14 · 2016: 19 · 2015: 17 · 2014: 22 · 2013: 15 · 2012: 24
FWCI: 1.96
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords: insulin-like growth factor I, growth hormone, IGF-1 receptor, insulin receptor, receptor heterodimerization, tyrosine kinase signaling, insulin-like growth factor II, insulin resistance, hyperglycemia, glucose metabolism, lipid metabolism, protein metabolism, diabetes treatment
MeSH terms: Animals, Humans, Insulin-Like Growth Factor I, Models, Biological, Growth Hormone, Models, Animal, Growth and Development, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks